Authors:
Lanier, ER
Sturge, G
McClernon, D
Brown, S
Halman, M
Sacktor, N
McArthur, J
Atkinson, JH
Clifford, D
Price, RW
Simpson, D
Torres, G
Catalan, J
Marder, K
Power, C
Hall, C
Romero, C
Brew, B
Citation: Er. Lanier et al., HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir, AIDS, 15(6), 2001, pp. 747-751
Authors:
Price, RW
Paxinos, EE
Grant, RM
Drews, B
Nilsson, A
Hoh, R
Hellmann, NS
Petropoulos, CJ
Deeks, SG
Citation: Rw. Price et al., Cerebrospinal fluid response to structured treatment interruption after virological failure, AIDS, 15(10), 2001, pp. 1251-1259
Authors:
Eberly, LE
Ohman, PA
Neaton, JD
Price, RW
Abrams, DI
Citation: Le. Eberly et al., Kaposi's sarcoma and central nervous system disease: a real association oran artifact of the control group?, AIDS, 14(8), 2000, pp. 995-1000
Citation: Rw. Price et al., Probing the silane, disilane and germane adsorption kinetics on the silicon (001) surface, J CRYST GR, 209(2-3), 2000, pp. 306-310
Authors:
Aweeka, F
Jayewardene, A
Staprans, S
Bellibas, SE
Kearney, B
Lizak, P
Novakovic-Agopian, T
Price, RW
Citation: F. Aweeka et al., Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex, J ACQ IMM D, 20(1), 1999, pp. 39-43
Authors:
Staprans, S
Marlowe, N
Glidden, D
Novakovic-Agopian, T
Grant, RM
Heyes, M
Aweeka, F
Deeks, S
Price, RW
Citation: S. Staprans et al., Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection, AIDS, 13(9), 1999, pp. 1051-1061
Authors:
Price, RW
Yiannoutsos, CT
Clifford, DB
Zaborski, L
Tselis, A
Sidtis, JJ
Cohen, B
Hall, CD
Erice, A
Henry, K
Citation: Rw. Price et al., Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy, AIDS, 13(13), 1999, pp. 1677-1685